[1]吕 冰,田利成,何振芬.呼气末二氧化碳分压监测在急性呼吸窘迫综合征机械通气中的应用[J].医学信息,2022,35(03):115-117.[doi:10.3969/j.issn.1006-1959.2022.03.028]
　LYU Bing,TIAN Li-cheng,HE Zhen-fen.Application of End-tidal Carbon Dioxide Partial Pressure Monitoring inMechanical Ventilation of Acute Respiratory Distress Syndrome[J].Medical Information,2022,35(03):115-117.[doi:10.3969/j.issn.1006-1959.2022.03.028]
点击复制

呼气末二氧化碳分压监测在急性呼吸窘迫综合征机械通气中的应用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年03期
页码:
115-117
栏目:
论著
出版日期:
2022-02-01

文章信息/Info

Title:
Application of End-tidal Carbon Dioxide Partial Pressure Monitoring inMechanical Ventilation of Acute Respiratory Distress Syndrome
文章编号:
1006-1959（2022）03-0115-03
作者:
吕 冰; 田利成; 何振芬
天津市宝坻区人民医院急诊科，天津 301800
Author(s):
LYU Bing; TIAN Li-cheng; HE Zhen-fen
Department of Emergency,Tianjin Baodi District People’s Hospital,Tianjin 301800,China
关键词:
呼气末二氧化碳分压; 急性呼吸窘迫综合征; 机械通气
Keywords:
End-expiratory carbon dioxide partial pressure; Acute respiratory distress syndrome; Mechanical ventilation
分类号:
R563.8
DOI:
10.3969/j.issn.1006-1959.2022.03.028
文献标志码:
A
摘要:
目的 研究呼气末二氧化碳分压监测在急性呼吸窘迫综合征机械通气中的应用效果。方法 选取2019年3月-2021年3月我院诊治的76例急性呼吸窘迫综合征患者为研究对象，采用随机数字表法分为对照组和观察组，各38例。两组均给予机械通气治疗，对照组未实施呼气末二氧化碳分压监测，观察组实施呼气末二氧化碳分压监测，比较两组治疗效果、心率恢复和呼吸窘迫缓解以及机械通气时间、血气指标[动脉血氧分压（PaO2）、动脉血二氧化碳分压（PaCO2）、动脉血氧饱和度（SaO2）、氧合指数（PaO2/FiO2）]、机械通气不良事件发生率。结果 观察组临床治疗总有效率为94.74%，高于对照组的81.58%，差异有统计学意义（P＜0.05）；观察组心率恢复、呼吸窘迫改善、机械通气时间短于对照组，差异有统计学意义（P＜0.05）；观察组PaCO2低于对照组，PaO2、SaO2、PaO2/FiO2高于对照组，差异有统计学意义（P＜0.05）；观察组机械通气不良事件发生率为5.26%，低于对照组的13.16%，差异有统计学意义（P＜0.05）。结论 在急性呼吸窘迫综合征机械通气中应用呼气末二氧化碳分压监测可提高临床治疗总有效率，促进心率恢复，缩短呼吸窘迫和机械通气时间，改善呼吸功能，且可降低机械通气不良事件发生率。
Abstract:
Objective To study the application effect of end-tidal carbon dioxide partial pressure monitoring in Acute respiratory distress syndrome ventilation.Methods A total of 76 patients with acute respiratory distress syndrome treated in our hospital from March 2019 to March 2021 were selected as the research subjects. They were divided into control group and observation group by random number table method, with 38 cases in each group. Both groups were treated with mechanical ventilation. The control group did not implement end-expiratory carbon dioxide partial pressure monitoring. The observation group implemented end-expiratory carbon dioxide partial pressure monitoring. The therapeutic effect, heart rate recovery and respiratory distress relief, mechanical ventilation time, blood gas indexes [partial pressure of oxygen in arterial-blood (PaO2), partial pressure of carbon dioxide in artery (PaCO2), blood oxygen saturation (SaO2), oxygenation index (PaO2/FiO2)], and incidence of mechanical ventilation adverse events were compared between the two groups.Results The total effective rate of clinical treatment in the observation group was 94.74%, which was higher than 81.58% in the control group, and the difference was statistically significant (P<0.05). The heart rate recovery time, respiratory distress improvement time and mechanical ventilation time in the observation group were shorter than those in the control group, and the differences were statistically significant (P<0.05). PaCO2 in the observation group was lower than that in the control group, PaO2, SaO2 and PaO2/FiO2 were higher than those in the control group, the differences were statistically significant (P<0.05). The incidence of adverse mechanical ventilation events in the observation group was 5.26%, which was lower than 13.16% in the control group, and the difference was statistically significant (P<0.05).Conclusion The application of end-tidal carbon dioxide partial pressure monitoring in mechanical ventilation of acute respiratory distress syndrome can improve the total effective rate of clinical treatment, promote heart rate recovery, shorten respiratory distress and mechanical ventilation time, improve respiratory function, and reduce the incidence of adverse events in mechanical ventilation.

参考文献/References:

[1]Fan E,Brodie D,Slutsky AS.Acute respiratory distress syndrome: advances in diagnosis and treatment[J].JAMA,2018,319(7):698-710.[2]孙峰,马士程,王亚.急诊呼气末二氧化碳监测专家共识[J].中华急诊医学杂志,2017,26(5):507-511.[3]诸澎伟,周晓娟,姜源渊.呼气末二氧化碳监测在儿童心肺复苏中的应用[J].海南医学,2015,26(23):3547-3549.[4]梁伟雄.肺保护性通气策略治疗急性呼吸窘迫综合征的临床探讨[J].中国临床研究,2015,27(5):535-536.[5]Chan MC,Tseng JS,Chiu JT,et al.Prognostic value of plateau pressure below 30 cmH2O in septic subjects with acute respiratory failure[J].Respir Care,2015,60(1):12-20.[6]周波,李东繁.两种肺复张方式对急性呼吸窘迫综合征患者呼吸力学及血管外肺水指数的影响[J].陕西医学杂志,2016,45(9):1122-1125.[7]张晓博,许运铎,白雪景,等.有创-无创序贯性机械通气联合肺复张治疗急性呼吸窘迫综合征临床观察 [J].河北医药,2015,37(15):2325-2327.[8]何宇刚.以氧合指数为控制窗的有创-无创序贯性机械通气在治疗ARDS中的应用[J].江苏医药,2015,41(4):444.[9]蔡英丽,任燕华,张聪.呼气末二氧化碳分压联合平台压监测在急性呼吸窘迫综合征机械通气中的应用[J].广东医学,2018,39(22):3368-3372,3376.[10]Lin QM,Fang XS,Zhou LL,et al.Changes of end-tidal carbon dioxide during cardiopulmonary resuscitation from ventricular fibrillation versus asphyxial cardiac arrest[J].World J Emerg Med,2014,5(2):116-121.[11]刘娜,李文强,高成伟,等.呼气末二氧化碳分压测定在慢性阻塞性肺疾病急性加重期中的应用[J].疑难病杂志,2017,16(3):339-341.[12]郑蓉.呼气末二氧化碳分压监测在新生儿呼吸窘迫综合征机械通气中的应用[J].蚌埠医学院学报,2014,39(10):1351-1352,1355.[13]宛洋,白静萱,董明月,等.允许性高碳酸血症在早产儿呼吸窘迫综合征治疗中的应用[J].中国小儿急救医学,2020,27(11):808-811.[14]梁庆标,杨灵,周丽欢,等.主流式呼气末 CO2 分压监测在慢性阻塞性肺疾病并呼吸衰竭中的临床价值[J].山西医药杂志,2018,47(4):417-419.[15]管癸芬,何钰熙,周泽和,等.呼气末二氧化碳分压在急诊危重症救治中的应用[J].黑龙江医学,2016,40(4):298-299.

相似文献/References:

[1]孙继飞,张 岚.肺表面活性物质治疗足月新生儿急性呼吸窘迫综合征疗效观察[J].医学信息,2019,32(02):121.[doi:10.3969/j.issn.1006-1959.2019.02.034]
　SUN Ji-fei,ZHANG Lan.Therapeutic Effect of Pulmonary Surfactant on Acute Respiratory Distress Syndrome in Full-term Neonates[J].Medical Information,2019,32(03):121.[doi:10.3969/j.issn.1006-1959.2019.02.034]
[2]徐雪峰.无创双水平气道正压通气在急性呼吸窘迫综合征患者中的应用效果分析[J].医学信息,2019,32(03):118.[doi:10.3969/j.issn.1006-1959.2019.03.037]
　XU Xue-feng.Analysis of Application Effect of Non-invasive Bi-level Positive Airway Pressure Ventilation in Patients with Acute Respiratory Distress Syndrome[J].Medical Information,2019,32(03):118.[doi:10.3969/j.issn.1006-1959.2019.03.037]
[3]郑 新,张 颖.血清TNF-α、IL-6、IL-8水平对ARDS患者病情的预测价值[J].医学信息,2020,33(04):177.[doi:10.3969/j.issn.1006-1959.2020.04.060]
　ZHENG Xin,ZHANG Ying.Predictive Value of Serum TNF-α,IL-6 and IL-8 Levels in Patients with ARDS[J].Medical Information,2020,33(03):177.[doi:10.3969/j.issn.1006-1959.2020.04.060]
[4]毛国华,李智铭,徐连生.PETCO2变化与老年肝脏切除术全麻患者容量反应严重程度的关系[J].医学信息,2020,33(10):78.[doi:10.3969/j.issn.1006-1959.2020.10.021]
　MAO Guo-hua,LI Zhi-ming,XU Lian-sheng.The Relationship Between PETCO2 Changes and the Severity of Volume Response in Elderly Patients Undergoing Hepatectomy under General Anesthesia[J].Medical Information,2020,33(03):78.[doi:10.3969/j.issn.1006-1959.2020.10.021]
[5]王 凯,田国栋.连续血液净化联合血必净对ARDS患者氧化应激、APACHEⅡ评分的影响[J].医学信息,2021,34(22):130.[doi:10.3969/j.issn.1006-1959.2021.22.040]
　WANG Kai,TIAN Guo-dong.Effect of Continuous Blood Purification Combined with Xuebijing on Oxidative Stress and APACHEⅡ Score in ARDS Patients[J].Medical Information,2021,34(03):130.[doi:10.3969/j.issn.1006-1959.2021.22.040]
[6]何广宾,左海涛,陈永青.呼吸机相关性肺炎对急性呼吸窘迫综合征患者预后的影响[J].医学信息,2022,35(11):89.[doi:10.3969/j.issn.1006-1959.2022.11.023]
　HE Guang-bin,ZUO Hai-tao,CHEN Yong-qing.Effect of Ventilator Associated Pneumonia on Prognosis of Patients with Acute Respiratory Distress Syndrome[J].Medical Information,2022,35(03):89.[doi:10.3969/j.issn.1006-1959.2022.11.023]
[7]张 曌,黄 斌.脓毒症并发ARDS的发病机制及预后评估研究进展[J].医学信息,2022,35(23):176.[doi:10.3969/j.issn.1006-1959.2022.23.039]
　ZHANG Zhao,HUANG Bin.Research Progress on Pathogenesis and Prognosis Evaluation of Sepsis Complicated with ARDS[J].Medical Information,2022,35(03):176.[doi:10.3969/j.issn.1006-1959.2022.23.039]
[8]康凤尔,姚 杨,曹晓梅,等.ECMO治疗急性呼吸窘迫综合征预后危险因素的Meta分析[J].医学信息,2023,36(23):22.[doi:10.3969/j.issn.1006-1959.2023.23.006]
　KANG Feng-er,YAO Yang,CAO Xiao-mei,et al.Meta-analysis of Prognostic Risk Factors of ECMO in the Treatment of Acute Respiratory Distress Syndrome[J].Medical Information,2023,36(03):22.[doi:10.3969/j.issn.1006-1959.2023.23.006]
[9]蒋 林,代 丹,尹琳琳,等.基于蒙特勒标准的新生儿急性呼吸窘迫综合征危险因素的Meta分析[J].医学信息,2025,38(03):39.[doi:10.3969/j.issn.1006-1959.2025.03.007]
　JIANG Lin,DAI Dan,YIN Linlin,et al.Meta-analysis of Risk Factors for Neonatal Acute Respiratory Distress Syndrome Based on Montreux Criteria[J].Medical Information,2025,38(03):39.[doi:10.3969/j.issn.1006-1959.2025.03.007]

更新日期/Last Update: 1900-01-01